{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Protein+Digestion&page=6", "query": { "condition": "Protein Digestion", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 298, "total_pages": 30, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Protein+Digestion&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Protein+Digestion&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-12T02:18:51.795Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01704521", "title": "Viral Kinetics in HCV Clearance in Subjects With Hemophilia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Hepatitis C", "Hemophilia" ], "interventions": [ { "name": "PegInterferon", "type": "DRUG" }, { "name": "Ribavirin", "type": "DRUG" }, { "name": "Telaprevir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kenneth Sherman", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2012-12", "completion_date": "2014-10", "has_results": true, "last_update_posted_date": "2015-04-06", "last_synced_at": "2026-11-12T02:18:51.795Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01704521" }, { "nct_id": "NCT06544265", "title": "SynKIR-310 for Relapsed/Refractory B-NHL", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "B Cell Lymphoma", "NHL, Adult", "Mantle Cell Lymphoma", "Relapsed Non-Hodgkin Lymphoma", "Refractory Non-Hodgkin Lymphoma", "Aggressive B-Cell Non-Hodgkin Lymphoma", "Indolent B-Cell Non-Hodgkin Lymphoma", "Follicular Lymphoma", "Marginal Zone Lymphoma", "DLBCL - Diffuse Large B Cell Lymphoma", "HGBL With MYC and BCL2 and/or BCL6 Rearrangements", "High-grade B-cell Lymphoma", "Diffuse Large B Cell Lymphoma", "Large B-cell Lymphoma", "T-Cell/Histiocyte Rich Lymphoma", "Non-hodgkin Lymphoma,B Cell", "Primary Mediastinal Large B-cell Lymphoma (PMBCL)", "Epstein-Barr Virus Positive DLBCL, Nos", "Follicular Lymphoma Grade 3B", "DLBCL (Diffuse Large B-Cell Lymphoma) Associated With Chronic Inflammation", "High Grade B-Cell Lymphoma, Not Otherwise Specified", "Follicular Lymphoma Grade 3", "Marginal Zone Splenic Lymphoma", "DLBCL", "Waldenstrom Macroglobulinemia", "Waldenstrom Macroglobulinaemia" ], "interventions": [ { "name": "SynKIR-310", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Verismo Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2024-11-01", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-04-14", "last_synced_at": "2026-11-12T02:18:51.795Z", "location_count": 5, "location_summary": "Denver, Colorado • Atlanta, Georgia • Fairway, Kansas + 2 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Fairway", "state": "Kansas" }, { "city": "New Brunswick", "state": "New Jersey" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06544265" }, { "nct_id": "NCT00810329", "title": "Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Fatigue Syndrome", "Fibromyalgia", "Gulf War Illness", "Multiple Chemical Sensitivity", "Interstitial Cystitis", "Irritable Bowel Syndrome" ], "interventions": [], "intervention_types": [], "sponsor": "Georgetown University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 160, "start_date": "2007-07", "completion_date": "2011-04", "has_results": false, "last_update_posted_date": "2014-02-25", "last_synced_at": "2026-11-12T02:18:51.795Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00810329" }, { "nct_id": "NCT05731141", "title": "A Prospective Natural History Study of Lymphatic Anomalies", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lymphatic Diseases", "Lymphatic Abnormalities" ], "interventions": [], "intervention_types": [], "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Day", "maximum_age": "100 Years", "sex": "ALL", "summary": "1 Day to 100 Years" }, "enrollment_count": 1200, "start_date": "2023-03-20", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-10-23", "last_synced_at": "2026-11-12T02:18:51.795Z", "location_count": 2, "location_summary": "Bethesda, Maryland • Philadelphia, Pennsylvania", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05731141" }, { "nct_id": "NCT01487031", "title": "Music Therapy on Nausea and Pain for Autologous Stem Cell", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Multiple Myeloma", "Non-Hodgkin Lymphoma", "Hodgkin Lymphoma" ], "interventions": [ { "name": "Music Therapy", "type": "OTHER" }, { "name": "No music therapy", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 108, "start_date": "2011-11", "completion_date": "2013-04", "has_results": false, "last_update_posted_date": "2013-08-02", "last_synced_at": "2026-11-12T02:18:51.795Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01487031" }, { "nct_id": "NCT04721912", "title": "Group B Streptococcus Response After Probiotic Exposure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Group B Strep Infection" ], "interventions": [ { "name": "Probiotic dietary supplement", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 68, "start_date": "2020-12-24", "completion_date": "2023-08-31", "has_results": true, "last_update_posted_date": "2025-01-14", "last_synced_at": "2026-11-12T02:18:51.795Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT04721912" }, { "nct_id": "NCT03797443", "title": "High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Metastatic Pancreatic Cancer" ], "interventions": [ { "name": "Ascorbic Acid", "type": "DRUG" }, { "name": "nab paclitaxel", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Piedmont Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2019-01-01", "completion_date": "2022-12", "has_results": false, "last_update_posted_date": "2019-05-31", "last_synced_at": "2026-11-12T02:18:51.795Z", "location_count": 3, "location_summary": "Atlanta, Georgia • Fayetteville, Georgia • Newnan, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Fayetteville", "state": "Georgia" }, { "city": "Newnan", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03797443" }, { "nct_id": "NCT07140120", "title": "LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cirrhosis, Liver", "Portal Hypertension" ], "interventions": [], "intervention_types": [], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 52, "start_date": "2023-06-13", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2026-07-22", "last_synced_at": "2026-11-12T02:18:51.795Z", "location_count": 3, "location_summary": "Ann Arbor, Michigan • Philadelphia, Pennsylvania • Dallas, Texas", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07140120" }, { "nct_id": "NCT07529808", "title": "Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Gastric Cancer", "Gastric Adenocarcinoma", "Gastric (Stomach) Cancer", "Gastroesophageal Adenocarcinoma", "Gastroesophageal Cancer (GC)", "Gastroesophageal Junction (GEJ) Adenocarcinoma", "Gastroesophageal Junction (GEJ) Cancer", "Gastrointestinal Cancer Metastatic", "Gastrointestinal Adenocarcinoma", "Gastrointestinal Cancers", "Colorectal (Colon or Rectal) Cancer", "Pancreatic Cancer", "CDH17-positive Advanced Solid Tumors", "Advanced Gastric Cancer" ], "interventions": [ { "name": "BHB810", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BigHat Biosciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 164, "start_date": "2026-07-16", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-10-20", "last_synced_at": "2026-11-12T02:18:51.795Z", "location_count": 3, "location_summary": "Duarte, California • Santa Monica, California • Fairfax, Virginia", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07529808" }, { "nct_id": "NCT02407561", "title": "Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rectal Adenocarcinoma", "Anal Adenocarcinoma", "Anal Squamous Cell Carcinoma" ], "interventions": [], "intervention_types": [], "sponsor": "Castle Biosciences Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2015-02", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2018-01-25", "last_synced_at": "2026-11-12T02:18:51.795Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02407561" } ] }